Literature DB >> 15362831

Culture and serologic survey for Mycobacterium avium subsp. paratuberculosis infection among southeastern white-tailed deer (Odocoileus virginianus).

William R Davidson1, Elizabeth J B Manning, Victor F Nettles.   

Abstract

From July 1998 through October 2002, radiometric culture (ileocecal lymph node, mesenteric lymph node, and feces) and serologic testing by enzyme-linked immunosorbent assay (ELISA) were used to survey white-tailed deer (Odocoilens virgianus) from the soutlheastern United States for infection by Mycobacterium avium subsp. paratuberculosis (Mptb), the causative agent of paratuberculosis (Johne's disease). Mycobacterium avium subsp. paratuberculosis was isolated from the ileocecal lymph node of one of 313 deer (0.3%) originating from 63 populations in Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, South Carolina, Tennessee, and West Virginia (USA). Six deer (2%), all from different populations, had ELISA results above a 0.25 sample-to-positive cutoff value, but none of the ELISA reactors originated from the population from which the single Mptb isolation was made. These six deer were seronegative when tested by agar gel immunodiffusion (AGID). Collectively, these data indicate that white-tailed deer currently do not constitute a broad regional reservoir for Mptb; however, further study is warranted to clarify the significance, if any, of infected deer to the epizootiology of paratuberculosis on a local scale. Adaptation and validation of an ELISA or another serologic assay for use with deer and other wildlife would markedly enhance Mptb surveillanece among wild populations and would be a powerful tool for gaining information on the role of wild species in epidemiology of paratuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362831     DOI: 10.7589/0090-3558-40.2.301

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  6 in total

1.  Immunoglobulin G1 enzyme-linked immunosorbent assay for diagnosis of Johne's Disease in red deer (Cervus elaphus).

Authors:  J Frank T Griffin; Evelyn Spittle; Christie R Rodgers; Simon Liggett; Marc Cooper; Douwe Bakker; John P Bannantine
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

2.  A novel cell wall lipopeptide is important for biofilm formation and pathogenicity of Mycobacterium avium subspecies paratuberculosis.

Authors:  Chia-wei Wu; Shelly K Schmoller; John P Bannantine; Torsten M Eckstein; Julia M Inamine; Michael Livesey; Ralph Albrecht; Adel M Talaat
Journal:  Microb Pathog       Date:  2009-02-05       Impact factor: 3.738

3.  Definitive differentiation between single and mixed mycobacterial infections in red deer (Cervus elaphus) by a combination of duplex amplification of p34 and f57 sequences and Hpy188I enzymatic restriction of duplex amplicons.

Authors:  Jacques Godfroid; Cathy Delcorps; Leonid M Irenge; Karl Walravens; Sylvie Marché; Jean-Luc Gala
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Suspicion of Mycobacterium avium subsp. paratuberculosis transmission between cattle and wild-living red deer (Cervus elaphus) by multitarget genotyping.

Authors:  Isabel Fritsch; Gabriele Luyven; Heike Köhler; Walburga Lutz; Petra Möbius
Journal:  Appl Environ Microbiol       Date:  2011-12-16       Impact factor: 4.792

5.  Sensitive and specific enzyme-linked immunosorbent assay for detecting serum antibodies against Mycobacterium avium subsp. paratuberculosis in fallow deer.

Authors:  José M Prieto; Ana Balseiro; Rosa Casais; Naiara Abendaño; Liam E Fitzgerald; Joseba M Garrido; Ramon A Juste; Marta Alonso-Hearn
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

6.  The modification and evaluation of an ELISA test for the surveillance of Mycobacterium avium subsp. paratuberculosis infection in wild ruminants.

Authors:  Mathieu Pruvot; Taya L Forde; Jillian Steele; Susan J Kutz; Jeroen De Buck; Frank van der Meer; Karin Orsel
Journal:  BMC Vet Res       Date:  2013-01-09       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.